KHARMS 22 ApS: Financial statements 2023
CVR: 31623162
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
KHARMS 22 ApS (CVR 31623162) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK -1,099 compared with DKK -1,777 the year before. Equity in the 2023 report amounted to DKK 141,932. The solvency ratio was 100%.
- Profit/Loss
- DKK -1,099
- Equity
- DKK 141,932
- Total Assets
- DKK 141,932
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | -1 t. | 142 t. | - |
| 2022 | - | - | -2 t. | 143 t. | - |
| 2021 | 0 | 0 | -513 | 145 t. | - |
| 2020 | 0 | 0 | 0 | 145 t. | - |
| 2019 | 0 | 0 | 0 | 145 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
KHARMS 22 ApS has published its annual report for 2022. The net result was DKK -1,777.
About KHARMS 22 ApS
KHARMS 22 ApS was a Danish company of the type Anpartsselskab based in Hillerød, founded in 2008. The company has been dissolved on 22 July 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. In 2024, the company reported a gross profit of DKK -1,188 and a net result of DKK -1,188 compared with DKK -1,099 the year before. Equity in the 2024 report amounted to DKK 140,744.